These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38419419)

  • 1. Body size, insulin sensitivity, metabolic health and risk of cardiovascular disease in Chinese adults: Insights from the China Cardiometabolic Disease and Cancer Cohort (4C) study.
    Hu C; Wang S; Lin H; Wan Q; Zheng R; Zhu Y; Li M; Xu Y; Xu M; Zheng J; Chen L; Zeng T; Hu R; Ye Z; Shi L; Su Q; Chen Y; Yu X; Yan L; Wang T; Zhao Z; Qin G; Chen G; Dai M; Zhang D; Tang X; Gao Z; Shen F; Gu X; Luo Z; Qin Y; Chen L; Hou X; Huo Y; Li Q; Wang G; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Deng H; Zhao J; Mu Y; Lai S; Li D; Ning G; Wang W; Hu W; Bi Y; Lu J;
    Diabetes Obes Metab; 2024 Jun; 26(6):2176-2187. PubMed ID: 38419419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study.
    Eckel N; Li Y; Kuxhaus O; Stefan N; Hu FB; Schulze MB
    Lancet Diabetes Endocrinol; 2018 Sep; 6(9):714-724. PubMed ID: 29859908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolically healthy obesity, transition to unhealthy metabolic status, and vascular disease in Chinese adults: A cohort study.
    Gao M; Lv J; Yu C; Guo Y; Bian Z; Yang R; Du H; Yang L; Chen Y; Li Z; Zhang X; Chen J; Qi L; Chen Z; Huang T; Li L;
    PLoS Med; 2020 Oct; 17(10):e1003351. PubMed ID: 33125374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolically Healthy Obesity and the Risk of Cardiovascular Disease in the Elderly Population.
    Dhana K; Koolhaas CM; van Rossum EF; Ikram MA; Hofman A; Kavousi M; Franco OH
    PLoS One; 2016; 11(4):e0154273. PubMed ID: 27100779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals.
    Voulgari C; Tentolouris N; Dilaveris P; Tousoulis D; Katsilambros N; Stefanadis C
    J Am Coll Cardiol; 2011 Sep; 58(13):1343-50. PubMed ID: 21920263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cardiovascular disease risk association with metabolic unhealthy obesity identified by body fat percentage and body mass index: Results from the 1999-2020 National Health and Nutrition Examination Survey.
    Xiong Q; Zhang Y; Li J; An Y; Yu S
    PLoS One; 2024; 19(8):e0305592. PubMed ID: 39141628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overweight or obesity increases the risk of cardiovascular disease among older Australian adults, even in the absence of cardiometabolic risk factors: a Bayesian survival analysis from the Hunter Community Study.
    Opio J; Wynne K; Attia J; Hancock S; Oldmeadow C; Kelly B; Inder K; McEvoy M
    Int J Obes (Lond); 2023 Feb; 47(2):117-125. PubMed ID: 36482073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study.
    Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
    Diabetes; 2005 Nov; 54(11):3252-7. PubMed ID: 16249452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome and cardiovascular disease in cancer survivors.
    Ueno K; Kaneko H; Suzuki Y; Okada A; Matsuoka S; Fujiu K; Michihata N; Jo T; Takeda N; Morita H; Kamiya K; Ako J; Node K; Yasunaga H; Komuro I
    J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):1062-1071. PubMed ID: 38515400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Insulin Resistance and Cardiovascular Disease Risk Varies According to Glucose Tolerance Status: A Nationwide Prospective Cohort Study.
    Wang T; Li M; Zeng T; Hu R; Xu Y; Xu M; Zhao Z; Chen Y; Wang S; Lin H; Yu X; Chen G; Su Q; Mu Y; Chen L; Tang X; Yan L; Qin G; Wan Q; Gao Z; Wang G; Shen F; Luo Z; Qin Y; Chen L; Huo Y; Li Q; Ye Z; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Deng H; Zhao J; Shi L; Ning G; Bi Y; Wang W; Lu J
    Diabetes Care; 2022 Aug; 45(8):1863-1872. PubMed ID: 35700159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolically Healthy Obese and Incident Cardiovascular Disease Events Among 3.5 Million Men and Women.
    Caleyachetty R; Thomas GN; Toulis KA; Mohammed N; Gokhale KM; Balachandran K; Nirantharakumar K
    J Am Coll Cardiol; 2017 Sep; 70(12):1429-1437. PubMed ID: 28911506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study.
    Elías-López D; Vargas-Vázquez A; Mehta R; Cruz Bautista I; Del Razo Olvera F; Gómez-Velasco D; Almeda Valdes P; Aguilar-Salinas CA;
    BMC Endocr Disord; 2021 Apr; 21(1):85. PubMed ID: 33910543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: The ATTICA cohort study.
    Kouvari M; Panagiotakos DB; Yannakoulia M; Georgousopoulou E; Critselis E; Chrysohoou C; Tousoulis D; Pitsavos C;
    Metabolism; 2019 Apr; 93():18-24. PubMed ID: 30639450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Overweight/Obesity Metabolic Phenotypes Defined by Two Criteria of Metabolic Abnormality and Cardiovascular Diseases: A Cross-Sectional Analysis in a Chinese Population.
    Qiu Y; Fan S; Liu J; He X; Zhu T; Yan L; Ren M
    Clin Cardiol; 2024 Oct; 47(10):e70020. PubMed ID: 39402891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity, metabolic health and clinical outcomes after incident cardiovascular disease: A nationwide population-based cohort study.
    Akyea RK; Ntaios G; Doehner W
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2653-2662. PubMed ID: 37806948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity measures, metabolic health and their association with 15-year all-cause and cardiovascular mortality in the SAMINOR 1 Survey: a population-based cohort study.
    Michalsen VL; Wild SH; Kvaløy K; Svartberg J; Melhus M; Broderstad AR
    BMC Cardiovasc Disord; 2021 Oct; 21(1):510. PubMed ID: 34674643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond BMI: The "Metabolically healthy obese" phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality -- a systematic review.
    Roberson LL; Aneni EC; Maziak W; Agatston A; Feldman T; Rouseff M; Tran T; Blaha MJ; Santos RD; Sposito A; Al-Mallah MH; Blankstein R; Budoff MJ; Nasir K
    BMC Public Health; 2014 Jan; 14():14. PubMed ID: 24400816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipocytokines, C-reactive protein, and cardiovascular disease: a population-based prospective study.
    Seven E; Husemoen LL; Sehested TS; Ibsen H; Wachtell K; Linneberg A; Jeppesen JL
    PLoS One; 2015; 10(6):e0128987. PubMed ID: 26035431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Residential Greenness, Cardiometabolic Disorders, and Cardiovascular Disease Among Adults in China.
    Yang BY; Hu LW; Jalaludin B; Knibbs LD; Markevych I; Heinrich J; Bloom MS; Morawska L; Lin S; Jalava P; Roponen M; Gao M; Chen DH; Zhou Y; Yu HY; Liu RQ; Zeng XW; Zeeshan M; Guo Y; Yu Y; Dong GH
    JAMA Netw Open; 2020 Sep; 3(9):e2017507. PubMed ID: 32955574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk in different obesity phenotypes over a decade follow-up: Tehran Lipid and Glucose Study.
    Mirzaei B; Abdi H; Serahati S; Barzin M; Niroomand M; Azizi F; Hosseinpanah F
    Atherosclerosis; 2017 Mar; 258():65-71. PubMed ID: 28213199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.